A report from the 27th annual congress of the European Association of Urology (February 24-28, 2012 - Paris, France)

• Autores: Xavier Rabasseda
• Localización: Medicamentos de actualidad = Drugs of today, ISSN 1699-3993, Vol. 48, Nº. 3, 2012, págs. 233-243
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Aging populations worldwide are already increasing the frequency of diseases of the urinary tract, including not just malignancies such as prostate and bladder cancer, but also common diseases of the aging male, such as benign prostatic hyperplasia, as well as age-facilitated diseases of women, such as urinary incontinence. Upon this background, the European Association of Urology (EAU) 2012 congress opened the gates in Paris, with attendees from across Europe and beyond crowding the Palais des Congres, as well as the subway lines leading to it. Four hectic days of oral and moderated poster sessions began, where leading scientists and researchers presented and discussed the results of clinical and preclinical research into many areas of urology related with the treatment and management of patients. The following report reviews many of these findings presented during the meeting, with a most direct impact on the current and future treatment for urological diseases.